Kyle Guse
2022
In 2022, Kyle Guse earned a total compensation of $1.5M as Chief Financial Officer, General Counsel and Secretary at Atossa Genetics, a 45% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $239,395 |
|---|---|
| Option Awards | $788,918 |
| Salary | $466,658 |
| Other | $32,900 |
| Total | $1,527,871 |
Guse received $788.9K in option awards, accounting for 52% of the total pay in 2022.
Guse also received $239.4K in non-equity incentive plan, $466.7K in salary and $32.9K in other compensation.
Rankings
In 2022, Kyle Guse's compensation ranked 2,158th out of 5,505 executives tracked by ExecPay. In other words, Guse earned more than 60.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,158 out of 5,505 | 61st |
Division Manufacturing | 1,160 out of 2,984 | 61st |
Major group Chemicals And Allied Products | 499 out of 1,339 | 63rd |
Industry group Drugs | 459 out of 1,242 | 63rd |
Industry Pharmaceutical Preparations | 333 out of 896 | 63rd |
Source: SEC filing on March 30, 2023.
Guse's colleagues
We found one more compensation record of an executive who worked with Kyle Guse at Atossa Genetics in 2022.
2022
Steven Quay
Atossa Genetics
Chief Executive Officer
News
Atossa Genetics CEO Steven Quay's 2022 pay falls 46% to $3.2M
March 30, 2023
Atossa Genetics CEO Steven Quay's 2021 pay jumps 101% to $5.9M
April 11, 2022
Atossa Genetics CEO Steven Quay's 2020 pay falls 49% to $2.9M
April 15, 2021
Atossa Genetics CEO Steven Quay's 2019 pay jumps 209% to $5.8M
April 13, 2020
Atossa Genetics CEO Steven Quay's 2018 pay jumps 84% to $1.9M
April 12, 2019